- Home
- PRTS vs APLT Comparison
PRTS vs APLT Comparison
Compare PRTS & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- APLT
- Stock Information
- Founded
- PRTS 1995
- APLT 2016
- Country
- PRTS United States
- APLT United States
- Employees
- PRTS N/A
- APLT N/A
- Industry
- PRTS Auto & Home Supply Stores
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- PRTS Consumer Discretionary
- APLT Health Care
- Exchange
- PRTS Nasdaq
- APLT Nasdaq
- Market Cap
- PRTS 51.3M
- APLT 42.5M
- IPO Year
- PRTS 2007
- APLT 2019
- Fundamental
- Price
- PRTS $0.75
- APLT $0.33
- Analyst Decision
- PRTS Buy
- APLT Buy
- Analyst Count
- PRTS 2
- APLT 7
- Target Price
- PRTS $1.40
- APLT $6.10
- AVG Volume (30 Days)
- PRTS 421.4K
- APLT 2.1M
- Earning Date
- PRTS 07-29-2025
- APLT 08-06-2025
- Dividend Yield
- PRTS N/A
- APLT N/A
- EPS Growth
- PRTS N/A
- APLT N/A
- EPS
- PRTS N/A
- APLT N/A
- Revenue
- PRTS $569,935,000.00
- APLT $265,000.00
- Revenue This Year
- PRTS $1.73
- APLT $1,768.13
- Revenue Next Year
- PRTS $5.48
- APLT $292.85
- P/E Ratio
- PRTS N/A
- APLT N/A
- Revenue Growth
- PRTS N/A
- APLT N/A
- 52 Week Low
- PRTS $0.68
- APLT $0.30
- 52 Week High
- PRTS $1.45
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- PRTS 42.34
- APLT 42.58
- Support Level
- PRTS $0.70
- APLT $0.30
- Resistance Level
- PRTS $0.95
- APLT $0.39
- Average True Range (ATR)
- PRTS 0.05
- APLT 0.03
- MACD
- PRTS -0.01
- APLT 0.00
- Stochastic Oscillator
- PRTS 31.64
- APLT 21.64
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.